World Heart Day: Although coronary artery disease primarily occurs in patients over the age of 40, experts stress that there has been a rising incidence of the disease in young adults.
The one-year-long study was aimed to evaluate the efficacy of LDH's digital therapeutics platform, Lyfe, on cardiovascular events, rehospitalisation, medication adherence, vital sign monitoring, and lifestyle changes among heart patients.
Lupin Digital Health, has unveiled the results of a first-of-its-kind study in India, showing the efficacy of digital therapeutics among patients with acute coronary syndrome and post-percutaneous coronary interventions.